Publications by authors named "T Ebata"

Objective: Osteoarthritis (OA) is a degenerative joint disease that has no cure, and current therapies are intended to minimize pain. There is, therefore, a need for effective pharmacologic agents that reverse or slow the progression of joint damage. We report herein on an investigation of the effects of intra-articular injections of ganglioside sugars on the progression of OA in an experimental rabbit model.

View Article and Find Full Text PDF

Background: We previously reported that the balance of short-chain fatty acids and lactic acid in feces affects postoperative infectious complications after major hepatectomy. However, the effect remains unclear in pancreaticoduodenectomy.

Methods: Preoperative fecal samples were collected from 210 patients who underwent pancreaticoduodenectomy at 2 institutions between January 2019 and June 2021.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the genetic heterogeneity and molecular profiles of bile tract cancer (BTC) using whole-genome sequencing to identify actionable gene mutations involved in its progression and treatment resistance.
  • The analysis of six BTC samples revealed a high average of somatic mutations with a significant prevalence of single nucleotide variants (SNVs), but no matching mutations were found in the existing cancer database.
  • Key findings suggest that samples without vascular invasion had a higher mutation prevalence, highlighting specific genes like ADAMTS7, AHNAK2, and CAPN10 that show differences in mutation rates between groups, emphasizing the complexity and genetic diversity of BTC.
View Article and Find Full Text PDF

Background: A histologically involved surgical margin (R1) is often observed after resection for cholangiocarcinoma. Compared with a negative margin (R0), R1 with invasive carcinoma (R1inv) markedly worsens survival, whereas the prognostic effect of R1 with carcinoma in situ (R1cis) remains controversial.

Methods: Patients who underwent resection for perihilar cholangiocarcinoma between 2002 and 2019 were retrospectively reviewed.

View Article and Find Full Text PDF